HER2 Support Group Forums - View Single Post - Top Abstracts in Breast Cancer 02/22/2006

al from Canada · 02-24-2006, 10:18 PM

TopAbstracts - Past 7 days

Vinorelbine in the management of breast cancer: New perspectives, revived role in the era of targeted therapy - (Cancer Treat Rev)
Incidence, Time Course, and Determinants of Menstrual Bleeding After Breast Cancer Treatment: A Prospective Study - (J Clin Oncol)
Breast cancer: achievements in adjuvant systemic therapies in the pre-genomic era - (Oncologist)
Clinical experience with pemetrexed in breast cancer - (Semin Oncol)
Role of gemcitabine in breast cancer management: an update - (Semin Oncol)

TopAbstracts - Past 3 months

02-24-2006, 10:18 PM	#1
al from Canada Senior Member Join Date: Jul 2005 Location: Ontario, Canada Posts: 722	Top Abstracts in Breast Cancer 02/22/2006 TopAbstracts - Past 7 days Vinorelbine in the management of breast cancer: New perspectives, revived role in the era of targeted therapy - *(Cancer Treat Rev)* Incidence, Time Course, and Determinants of Menstrual Bleeding After Breast Cancer Treatment: A Prospective Study - *(J Clin Oncol)* Breast cancer: achievements in adjuvant systemic therapies in the pre-genomic era - *(Oncologist)* Clinical experience with pemetrexed in breast cancer - *(Semin Oncol)* Role of gemcitabine in breast cancer management: an update - *(Semin Oncol)* TopAbstracts - Past 3 months Two Concurrent Phase II Trials of Paclitaxel/ Carboplatin/Trastuzumab (Weekly or Every-3-Week Schedule) as First-Line Therapy in Women with HER2-Overexpressing Metastatic Breast Cancer: NCCTG Study 983252 - *(Clin Breast Cancer)* Adjuvant chemotherapy for early breast cancer: optimal use of epirubicin - *(Oncologist)* Dose-Dense Adjuvant Chemotherapy in Early Breast Cancer Patients: Results From a Randomized Trial - *(J Natl Cancer Inst)* Pre-operative systemic (neo-adjuvant) therapy with trastuzumab and docetaxel for HER2-overexpressing stage II or III breast cancer: results of a multicenter phase II trial - *(Ann Oncol)* Comparison of rapidly cycled tandem high-dose chemotherapy plus peripheral-blood stem-cell support versus dose-dense conventional chemotherapy for adjuvant treatment of high-risk breast cancer: results of a multicentre phase III trial - *(Lancet)* __________________ Primary care-giver to and advocate for Linda, who passed away April 27, 2006.